From Paris to Seoul: The Forces Reshaping Global Cosmetic Ingredient Science

From Paris to Seoul: The Forces Reshaping Global Cosmetic Ingredient Science

The first half of 2026 has already delivered a seismic shift in how the cosmetics industry approaches ingredient innovation, regulation, and global trade. From Chinese brands debuting as raw-material suppliers at the world’s premier ingredient exhibition to AI-powered RNA technology entering the skincare aisle, the landscape is moving faster than ever. Here are the five stories every skincare professional needs to know.

1. In-Cosmetics Global 2026: Asia’s Ingredient Suppliers Take Center Stage in Paris

The annual in-cosmetics Global exhibition returned to Paris Porte de Versailles from April 14–16, drawing over 1,100 exhibitors and 16,000+ industry professionals under the theme “Science as Core, Beauty Reborn.” The dominant storyline, however, was not another European chemical giant — it was the arrival of Chinese ingredient houses as serious innovators.

Botanee’s Yunnan Specialty Plant Extraction Laboratory showcased a portfolio of self-developed highland botanical extracts, demonstrating that Chinese raw-material research has matured beyond commodity supply. Meanwhile, Chinese skincare brand Guyu (via its subsidiary Qingwen Bio) made its debut as an ingredient supplier — not a buyer — a symbolic milestone for the domestic industry. Perhaps most striking was Digitalgene.AI, which presented its AI-driven siRNA (small interfering RNA) skincare ingredients to a global audience for the first time, generating significant buzz among formulation scientists.

Source: Tencent News / qq.com · Guyu at in-cosmetics Global

2. AI Meets RNA: siRNA Technology Targets Melanin at the Genetic Instruction Layer

The breakout technology at in-cosmetics Global 2026 came from Shanghai-based Digitalgene.AI, which demonstrated that small interfering RNA — a technology that won the 2006 Nobel Prize and has been used in pharmaceuticals since 2018 — can now be applied to topical skincare.

Using proprietary AI+RNA platforms (OmicsApex for target discovery, MolOptima for molecular design), the company claims it can screen billions of sequences and identify optimal siRNA candidates within 6–9 months. Their lead brightening ingredient, KeBaiYin, works by degrading tyrosinase mRNA to suppress melanin synthesis at the source — rather than inhibiting the enzyme after it forms. A separate anti-aging candidate, KeSuYin, targets matrix metalloproteinase (MMP) mRNA to prevent collagen breakdown. Both compounds achieved statistically significant results in 28-day human trials, with skin permeation reaching the dermal layer within one hour. The research has been published via IFSCC 2025.

Source: Digitalgene.AI at In-Cosmetics Global 2026

3. EU SCCS Issues Final Opinion on CBD in Cosmetics

On April 24, 2026, the European Union’s Scientific Committee on Consumer Safety (SCCS) published its long-awaited final opinion on cannabidiol (CBD) as a cosmetic ingredient. The opinion addresses safe concentration limits, exposure scenarios, and toxicological data requirements for CBD in leave-on and rinse-off products.

This ruling is expected to have far-reaching implications: brands that have been awaiting regulatory clarity before launching CBD-infused skincare lines in the EU market now have a definitive framework. Conversely, formulators in regions without equivalent guidance (including parts of Southeast Asia) will likely reference the SCCS opinion as a de facto safety benchmark. The full text is available on the SCCS website.

Source: CIRS Group Regulatory News

4. South Korea Expands Ingredient Testing Standards with 18 New Analytical Methods

South Korea’s National Institute of Food and Drug Safety Evaluation (NIFDS) released a draft revision on April 21, 2026, adding 18 new analytical methods for restricted cosmetic ingredients while also updating test protocols for triclosan and zinc pyrithione. The revision was circulated through the Korea Cosmetic Association (KCIA) for public comment, which closed on April 24.

For brands exporting to South Korea — the fourth-largest beauty market globally — this signals stricter enforcement and more granular compliance requirements. Companies sourcing multi-ingredient formulations should expect additional documentation and testing data to clear customs under the revised guidelines.

Source: CIRS Group — Personal Care Products

5. China Tightens Cosmetic Import-Export Inspection Under New GACC Measures

On May 11, 2026, China’s General Administration of Customs (GACC) issued Announcement No. 61 of 2026, clarifying declaration, record-keeping, and pre-export inspection requirements for cosmetics under the newly revised inspection and quarantine measures. The announcement specifies procedural obligations for both importers and exporters, with particular emphasis on ingredient documentation and product classification accuracy.

This development is critical for international brands eyeing the Chinese market and for Chinese companies exporting to Southeast Asia and beyond. The updated framework aligns China’s customs procedures more closely with international best practices while raising the compliance bar for cross-border cosmetic trade.

Source: ChemLinked Cosmetic News

What This Means for Formulators

The convergence of these five developments points to a clear trajectory: the cosmetic ingredient industry is becoming more scientific, more regulated, and more Asia-centric. AI-driven molecular design is compressing R&D timelines, RNA-based active ingredients are redefining what “efficacy” means at the cellular level, and governments across the EU, South Korea, and China are simultaneously tightening safety frameworks. For brands and formulators who stay ahead of these curves, the opportunities are significant — but so is the cost of falling behind.